- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: GSK573719/GW642444 62.5/25
Total 74 results
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveSouth Africa, United States, Canada, Ukraine, United Kingdom, Denmark, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveTaiwan, Thailand, China, Philippines, Korea, Republic of
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Russian Federation, United States, Bulgaria, Estonia, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Ukraine, Germany, Peru, Poland, France, Romania, Italy, Mexico
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Australia, United States, Germany, Chile, Korea, Republic of, Mexico, Canada, South Africa, Romania
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Chile, South Africa, Romania, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Queen's UniversityGlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Ukraine, Estonia, Belgium, France, Sweden, Netherlands, Philippines, Denmark, Hungary, Norway, Slovakia
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Estonia, Canada, Chile, Germany, Peru, Philippines, Mexico, Korea, Republic of, Denmark, Russian Federation, Poland, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUkraine, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Estonia
-
Novartis PharmaceuticalsCompletedHypertensionUnited States, Belgium, Hungary, Turkey, Guatemala, Slovakia, Germany, Puerto Rico, Poland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveChina
-
Novartis PharmaceuticalsCompleted
-
NYU Langone HealthCompleted
-
Idorsia Pharmaceuticals Ltd.Janssen Biotech, Inc.CompletedResistant HypertensionSpain, Israel, Czechia, United States, Canada, China, Hungary, Netherlands, Poland, United Kingdom, Germany, Australia, Belgium, Finland, France, Greece, Italy, Lithuania, Russian Federation, Ukraine
-
Eisai Inc.Completed
-
GlaxoSmithKlineCompleted
-
Repros Therapeutics Inc.CompletedUterine FibroidsUnited States
-
Aclaris Therapeutics, Inc.CompletedSeborrheic Keratosis (SK)United States
-
Cairo UniversityNorhan Abdel Aleem Ali; Hagar hassanein refaee; Ahmed Abdullah Fathi Mohamed...CompletedThree Different Doses of Intrathecal Hyperbaric Prilocaine With FentanylEgypt
-
Guangdong Zhongsheng Pharmaceutical Co., Ltd.CompletedSolid Tumor | Idiopathic Pulmonary Fibrosis(IPF)China
-
Mesoblast, Inc.CompletedAcute Myocardial Infarction
-
UCB PharmaCompletedEpilepsyUnited States, Australia, Canada, Brazil, Mexico
-
UCB PharmaCompletedUnverricht-Lundborg DiseaseUnited States, Canada, Finland, France, Israel, Russian Federation, Serbia, Tunisia
-
National Institute of Respiratory Diseases, MexicoCompleted
-
Sunovion Respiratory Development Inc.Completed
-
GlaxoSmithKlineQ2 Solutions; York Bioanalytical Solution; BI Medical.Inc; SRL Mediserch.Inc; Parexel...Completed
-
GlaxoSmithKlineCompletedAsthmaAustralia, United States, Argentina, Canada, Germany, Japan, Korea, Republic of, Romania, Russian Federation, Spain, South Africa, Netherlands, Poland, Italy, United Kingdom
-
IntegoGen, LLCWithdrawnHidradenitis SuppurativaUnited States
-
Alimentiv Inc.AbbottTerminated
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Chile, South Africa, Romania, Mexico, Norway
-
GlaxoSmithKlineWithdrawnPulmonary Disease, Chronic ObstructiveCanada, Germany
-
Yuhan CorporationCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Sweden, New Zealand, Russian Federation, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Canada, Germany, Spain, United States, Italy, Netherlands, South Africa, Sweden, France, Mexico, Australia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Romania, Russian Federation, Spain, Bulgaria, Canada, Hungary, Argentina
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Ukraine, United States, Estonia, South Africa, Sweden, Norway, Russian Federation, Korea, Republic of
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, France, Germany, Russian Federation, Ukraine, Italy, Norway
-
Creighton UniversityWithdrawn
-
Repros Therapeutics Inc.Completed
-
Statens Serum InstitutCompleted
-
AstraZenecaSt. John's Research InstituteCompletedPrimary HypertensionIndia
-
GlaxoSmithKlineCompletedMetabolic, CardiovascularUnited Kingdom
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedFocus of the Study: Normal VolunteersUnited States